BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8691235)

  • 1. Monoclonal antibody scan holds promise for prostate cancer staging.
    Kotz D
    J Nucl Med; 1996 Apr; 37(4):11N-12N, 15N. PubMed ID: 8691235
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunoscintigraphy of prostatic cancer].
    Aliaev IuG; Vinarov AZ; Rapoport LM; Bezrukov EA; Butnaru DV
    Urologiia; 2006; (4):67-9. PubMed ID: 17058687
    [No Abstract]   [Full Text] [Related]  

  • 3. Radioimmunoscintigraphy for prostate cancer.
    Tecnologica MAP Suppl; 1998 Feb; ():26-31. PubMed ID: 10183357
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo behavior of 111In-labeled monoclonal anti-prostatic acid phosphatase antibody after intraprostatic and intravenous injections.
    Kairemo KJ; Rannikko S; Nordling S; Savalainen S; Ahonen A; Taavitsainen MJ; Alfthan OS
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):151-5. PubMed ID: 7632761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capromab pendetide imaging of occult lymph node metastases.
    Haseman MK
    J Nucl Med; 1998 Apr; 39(4):653. PubMed ID: 9544674
    [No Abstract]   [Full Text] [Related]  

  • 6. Radioimmunodetection of prostate cancer by 111In-labeled monoclonal antibody against prostatic acid phosphatase.
    Ahonen A; Kairemo K; Karnani P; Heikkilä J; Nurmi M; Teräs M; Lukkarinen O
    Acta Oncol; 1993; 32(7-8):723-7. PubMed ID: 8305218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PROSTASCINT scan for staging prostate cancer.
    Lange PH
    Urology; 2001 Mar; 57(3):402-6. PubMed ID: 11248606
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoclonal antibody imaging of recurrent and metastatic prostate cancer.
    Burgers JK; Hinkle GH; Haseman MK
    Semin Urol; 1995 May; 13(2):103-12. PubMed ID: 7638467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible false-positive metastatic prostate cancer on an In-111 capromab pendetide scan as a result of a pelvic kidney.
    Valliappan S; Joyce JM; Myers DT
    Clin Nucl Med; 1999 Dec; 24(12):984-5. PubMed ID: 10595486
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate cancer abdominal metastases detected with indium-111 capromab pendetide.
    Hinkle GH; Burgers JK; Olsen JO; Williams BS; Lamatrice RA; Barth RF; Rogers B; Maguire RT
    J Nucl Med; 1998 Apr; 39(4):650-2. PubMed ID: 9544673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer imaging with a new monoclonal antibody: a preliminary report.
    Sanford E; Grzonka R; Heal A; Helal M; Persky L; Tyson I
    Ann Surg Oncol; 1994 Sep; 1(5):400-4. PubMed ID: 7850541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography and molecular imaging of the prostate: an update.
    Lawrentschuk N; Davis ID; Bolton DM; Scott AM
    BJU Int; 2006 May; 97(5):923-31. PubMed ID: 16643472
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioimmunoscintigraphy of pelvic lymph nodes with 111indium-labeled monoclonal antibody CYT-356.
    Babaian RJ; Sayer J; Podoloff DA; Steelhammer LC; Bhadkamkar VA; Gulfo JV
    J Urol; 1994 Dec; 152(6 Pt 1):1952-5. PubMed ID: 7966649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies and radioimmunoconjugates in the diagnosis and treatment of prostate cancer.
    Abdel-Nabi H; Wright GL; Gulfo JV; Petrylak DP; Neal CE; Texter JE; Begun FP; Tyson I; Heal A; Mitchell E
    Semin Urol; 1992 Feb; 10(1):45-54. PubMed ID: 1565904
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of radioimmunolocalization in the staging of gastric carcinoma.
    Mussa A; Sandrucci S; Mobiglia A; Baccega M; Mussa B; De Filippi PG
    Semin Surg Oncol; 1998 Dec; 15(4):209-11. PubMed ID: 9829372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-isotope protocol for indium-111 capromab pendetide monoclonal antibody imaging.
    Kelty NL; Holder LE; Khan SH
    J Nucl Med Technol; 1998 Sep; 26(3):174-7. PubMed ID: 9755436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate specific antigen in the diagnosis and staging of prostate cancer.
    Jung P; Wolff JM; Mattelaer P; Jakse G
    Acta Urol Belg; 1996 Sep; 64(3):1-6. PubMed ID: 8946774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of prostate-specific antigen and ultrasonography in the evaluation of patients with carcinoma of the prostate.
    Santucci RA; Brawer MK
    Semin Urol; 1994 Nov; 12(4):252-64. PubMed ID: 7533319
    [No Abstract]   [Full Text] [Related]  

  • 19. Single photon emission computerized tomography with capromab pendetide plus computerized tomography image set co-registration independently predicts biochemical failure.
    Ellis RJ; Zhou EH; Fu P; Kaminsky DA; Sodee DB; Faulhaber PF; Bodner D; Resnick MI
    J Urol; 2008 May; 179(5):1768-73; discussion 1773-4. PubMed ID: 18343445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of (111)In Capromab Pendetide (Prosta-ScintR) immunoscintigraphy in the management of prostate cancer.
    Freeman LM; Krynyckyi BR; Li Y; Korupulu G; Saleemi K; Haseman MK; Kahn D;
    Q J Nucl Med; 2002 Jun; 46(2):131-7. PubMed ID: 12114876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.